On Thursday, the top 5 biggest gainers included Ocean Power Technologies, Inc. (OPTT), a company servicing the Industrial Goods. Ocean Power Technologies, Inc. is up 75.29% today so far in trading, or 2.21. The price at time of writing is 5.14 with a volume of 7,003,700.
Ocean Power Technologies, Inc. develops and commercializes proprietary systems that generate electricity by harnessing the renewable energy of ocean waves primarily in the United States, Europe, Asia, and Australia. It offers autonomous PowerBuoy system that is designed to generate power for use independent of the power grid in remote locations. The company focuses on serving public and private entities, and agencies that use electricity in and near the ocean.
In addition, Kura Oncology, Inc. (KURA) also showed leading gains, posting an increase of 39.52% since prior closing. Kura Oncology, Inc. services the Healthcare sector of the market. The price at time of writing is 5.19 with a volume of 2,120,825.
Developing in-licensed protein inhibitors for solid tumors and blood cancers.
Next is Odyssey Marine Exploration Inc. (OMEX), a company in the Services sector. Odyssey Marine Exploration Inc. is showing gains of 14.08% today, which is up 0.32. The price at time of writing is 2.60 with a volume of 127,770.
Odyssey Marine Exploration, Inc., together with its subsidiaries, engages in deep-ocean exploration activities worldwide. The company provides exploration services, including geophysical and geotechnical assessments of seabed mineral deposits to companies. It also sells recovered cargoes, such as coins, bullion, and merchandise, as well as charters or leases its marine exploration equipment, vessels, and services.
Vermillion, Inc. (VRML), in the Healthcare sector, is showing 13.04% gains. The price at time of writing is 1.30 with a volume of 282,633.
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. The company’s lead in vitro diagnostic test is Overa, a blood test to aid physicians in pre-surgical assessment of ovarian tumors for malignancy, using an ialgorithmic approach.
And lastly: Cree, Inc. (CREE), which is in the Technology sector, has 11.96% gains (which is 3.00 in dollars) so far today. The price at time of writing is 28.08 with a volume of 4,621,516.
Cree, Inc. provides lighting-class light emitting diode (LED), lighting, and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, South Korea, Japan, Malaysia, Taiwan, and internationally. Its Lighting Products segment offers LED lighting systems and bulbs for use in settings, such as office and retail space, restaurants and hospitality, schools and universities, manufacturing, healthcare, airports, municipal, residential, street lighting and parking structures, and other applications. This segment sells its products to distributors, retailers, and customers. The company’s LED Products segment provides blue and green LED chip products for use in various applications, including video screens, gaming displays, function indicator lights and automotive backlights, headlamps, and directional indicators.